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Abstract
CD4+ T-cell mediated Th1 immune responses are critical for immunity to TB. The immuno-
modulatory protein, lymphocyte activation gene-3 (LAG-3) decreases Th1-type immune
responses in T-cells. LAG-3 expression is significantly induced in the lungs of macaques
with active TB and correlates with increased bacterial burden. Overproduction of LAG-3
can greatly diminish responses and could lead to uncontrolled Mtb replication. To assess
the effect of LAG-3 on the progression of Mtb infection, we developed a co-culture system
wherein blood-derived macrophages are infected with Mtb and supplemented with macaque
blood or lung derived CD4+ T-cells. Silencing LAG-3 signaling in macaque lung CD4+ T-
cells enhanced killing of Mtb in co-cultures, accompanied by reduced mitochondrial electron
transport and increased IFN-γ expression. Thus, LAG-3 may modulate adaptive immunity to
Mtb infection by interfering with the mitochondrial apoptosis pathway. Better understanding
this pathway could allow us to circumvent immune features that promote disease.
Introduction
Mtb, the causative agent of TB results in approximately 1.4 million deaths annually [1, 2].
Additionally, 9 million individuals are newly infected with Mtb each year [3]. The interaction
between the phagocytes and T-cells within the lung granuloma are key for the control of Mtb.
Modulation of the Th1 immune response, which can potentially sterilize infection, is required
for control of tissue damaging immunopathology, but may provide the bacillus with a niche to
persist [4]. Immunosuppression can modulate T-cell function through a decreased ability to
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recognize antigen, activate, proliferate, produce cytokines or eventually, increased exhaustion
[5–7], potentially resulting in the loss of containment of Mtb [8, 9].
The lung granuloma is crucial in the determination of whether Mtb infection results in
control or progression of TB [10]. The classical Mtb induced lung granuloma in humans is a
stratified, well-organized structure. It consists of a central region containing Mtb-infected
monocyte-derived cells [11] and is surrounded by uninfected monocyte-derived cells, includ-
ing alveolar macrophages, dendritic cells, and epitheleoid macrophages. These are in turn
encircled by lymphocytic cells, such as T and B cells [12]. Both phagocytic cells and T-cells are
key for the control of Mtb. Phagocytic cells; especially macrophages are part of the first line of
defense against the pathogen. After uptake of the bacillus, these cells can inhibit mycobacterial
replication and even neutralize the pathogen itself through a plethora of mechanisms including
phagosomal maturation and phagolysosomal fusion, with bactericidal activity due to acidifica-
tion, and reactive oxygen and nitrogen intermediates [13–15]. T cells are also indispensable in
their action towards the containment of Mtb, where T-cells primarily function through the
production of Th1 cytokines [16–18]. The release of IFN-γ, TNF-α, and IL-2 allow for activa-
tion of macrophages, immune cell recruitment, and greater T cell proliferation [19, 20].
While too great an inflammatory response may lead to immunopathogenesis, resulting in
the loss of integrity in the granuloma structure [21, 22], an overabundance of immunomodula-
tory molecules can also cause immunosuppression, e.g. with IL-10 overexpression [23]. In
either case, the end result is a loss of control of bacterial replication. An increased presence of
these immunosuppressive molecules can cause decreased T cell function through a decreased
ability to recognize antigen, become activated, proliferate, produce cytokines or eventually
though exhaustion [5–7]. Any of the above could lead to the loss of containment of Mtb, and
evasion of the pathogen from the immune response [8, 9].
LAG-3 acts as a negative co-stimulatory receptor (checkpoint inhibitor) that inhibits
immune response by competitively inhibiting the CD4-MHC-II antigen presentation interac-
tion [24]. LAG-3 dampens the Th1 immune response through the activation and resulting pro-
liferation of Tregs, T cell dysregulation, as well has the inhibition of monocyte differentiation;
both of which have a deleterious downstream effect on Th1 effector T-cell activation, prolifera-
tion and function [7, 24–26]. Blocking of LAG-3 signaling resulted in increased antigen pre-
sentation creating an elevated Th1 response with increased production of IFN-γ [27]. LAG-3
expressing T-cells are functionally exhausted and correlate with HIV disease in macaques [28].
As a checkpoint inhibitor, LAG-3 depletion is currently in clinical trials for cancer immuno-
therapy [29, 30]. LAG-3 may be a more appropriate checkpoint inhibitor target than PD-1
since interference with the latter only results in the activation of effector T-cells, while antago-
nizing the former can additionally inhibit the suppressive action of Tregs.
LAG-3 is significantly induced (~100 fold) in human like macaque lungs during active TB
[31, 32] and is specifically localized to groups of T-cells, including Tregs, as well as NK cells
[32]. LAG-3 expression in macaque lungs correlates with higher Mtb burden [31, 32]. Further-
more, majority of LAG-3 expression occurred on CD4+ T-cells in the lung granuloma, in
macaques with active TB and to a lower extent, in animals where LTBI was reactivated due to
co-infection with SIV. Further, these cells also co-expressed IL-10. LAG-3 was not however,
expressed in lungs of animals with LTBI, or animals infected with SIV or pulmonary bacterial
pathogens other than Mtb. Together, these data suggest a potential role for this known mod-
ulator of Th1 responses in TB [7, 24]. Thus, a strong rationale exists for studying the role
played by LAG-3 in negatively regulating immune responses in TB.
We sought to understand the role of LAG-3 in modulating host responses to TB with a sim-
plistic co-culture model consisting of Mtb-infected differentiated macaque macrophages and
CD4+ T cells—the two major cellular populations within a granuloma. CD4+ cells were derived
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from either the blood or the lungs of Mtb-infected NHPs. siRNA was used to silence the
expression of LAG-3 within a subset of CD4+ cells before co-culturing (relative to controls
with scrambled, nonspecific siRNA). In-vitro models of Mtb-infected macrophages have been
extensively employed [33–35]. The aim was to understand if their interaction with CD4+ cells
could mimic in-vivo interactions. Further, we sought to specifically understand if blockading
LAG-3 signaling would have a perceivable impact on the function of CD4+ cells (e.g. greater
activation), resulting in the control of Mtb. To test this hypothesis, we measured Mtb burdens
in such co-cultures over the course of time (0–96 hrs) and assessed T cell phenotype, cytokine
production and transcriptomics at specific time-points where samples could be banked.
Materials and methods
The Tulane National Primate Research Center Institutional Animal Care and Use Committee
(IACUC) and the Tulane Institutional Biosafety Committee (IBC) approved all procedures.
Co-cultures
PBMCs were isolated from EDTA treated blood of infected rhesus macaques and plated into
12-well Poly-L-Lysine coated plates in antibiotic containing complete RPMI for 4h to allow for
adherence and then differentiated for 120h before Mtb infection [36]. T-cells were collected
from both the blood and dematricized [37] lungs of animals with active TB [32, 38, 39]. Both
blood and lung tissue was collected from macaques on an approved and previously completed
study [40] and banked for future use. CD4+ T-cells were isolated via density gradient centrifu-
gation using Histopaque-1077 using negative selection with a MACS NHP CD4+ T-cell Isola-
tion Kit (Miltenyi). Mononuclear cells were passed through MS columns affixed to the
OctoMACS™ Separator Magnet and the unlabeled CD4+ T-cell population collected and cryo-
preserved. The differentiated macrophages were infected with Mtb at an MOI of 5:1 for 4h [33,
34, 41], which was deemed time-point 0. CD4+ T-cells were then supplemented to the culture
at a 1:1 ratio to macrophages (~5x105 CD4+ T-cells) (S1 Fig). Samples were collected at 0, 4,
24, 48, 72, and 96h post-infection for CFU as described earlier [33, 34, 41].
LAG-3 siRNA transfection in CD4+ T-cells
siRNA transfection has previously been described [34, 42]. siRNAs for LAG-3, Cyclophilin B
as positive control, and non-specific negative control (S2 Fig) were combined with the trans-
fection reagent (Dharmacon) for 20 minutes and added to CD4+s, which were then incubated
for 24h before being added to Mtb-infected macrophage culture. Mtb CFU assays in cultures
were performed as described earlier [33, 34, 41].
Flow cytometry, confocal microscopy and cytokine assays
Flow cytometry was performed on co-cultured T-cells as previously described [31, 32, 40, 43–
45] (S1 Table). Confocal microscopy was performed on fixed adherent differentiated macro-
phages and co-cultures [32–34, 38] and cytokine assays on supernatant, as described earlier
[32–34, 42]. Mtb-specificity of blood or lung-derived T-cells was identified by stimulating with
either a positive control, or a negative control or Mtb CW (BEI Resources) as previously
described [40, 46].
RNA extraction, quantitative RT-PCR and transcriptomics
RNA extraction and cDNA synthesis were performed as described earlier [32–34, 41].
RT-PCR was performed in duplicate and data analyzed as described earlier [32]. RNA was
The effect of LAG-3 on T-cells in TB
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amplified and used for microarrays [31, 38, 40, 44, 47–49]. RNA from uninfected macrophages
was used as baseline. For statistical analysis of pathways and categories, we used DAVID (The
Database for Annotation, Visualization and Integrated Discovery) v6.7 (https://david.ncifrcf.
gov) [40, 44]. Genes with at least a two-fold induction were uploaded to DAVID to identify sta-
tistically significant accumulation of genes across Gene Ontology. Gene expression data was
uploaded to Gene Expression Omnibus (GEO) and can be retrieved using the accession num-
ber (GPL10183).
Statistics
For most analyses, we first determined if the data were normally distributed or not. Since in
almost all instances, data did not significantly depart from normality, we used a non-paramet-
ric Mann-Whitney U test to assess statistical significance of the results. For transcriptomics
analyses, we identified terms with false-discovery rate (FDR) corrected p-values of 0.05 or less
as significantly accumulated. P-values were transformed to negative log10 values to provide
visual assessment of the magnitude of significant shift.
Results
Establishment of the Mtb-infected macrophage-T-cell co-culture model
We first compared Mtb infection in NHP blood-derived monocytes differentiated for 24h
(T24 monocytes) versus macrophages differentiated for 120h (T120 differentiated macro-
phages) (S1 Fig). The latter were more efficient at initial bacterial uptake when compared to
T24 monocytes (Fig 1A), with an initial bacterial burden of 1.7x105 CFU/mL, ~25 times
greater than in the T24 monocyte group (5.0x103 CFU/mL) (P>0.0001). Since the data were
not significantly departed from normality, we used a non-parametric Mann-Whitney U test to
assess the statistical significance of these results. The differences between the T24 monocyte
and the T120 macrophage groups were significant at 0 (P<0.01), 4 (P<0.01) and 24 (P<0.05)
hrs. The differences at 0 and 4 hr were also statistically significant after the application of Bon-
ferroni correction.
The cellular morphology of T24 monocytes was typical of undifferentiated monocytes (Fig
1B), with all cells appearing fairly homogenous and maintaining a round shape. In contrast,
the cells differentiated for 120h had heterogeneous morphology with signs of differentiation,
including macrophage-like characteristics such as: elongated cell bodies, and diffused and
amoeboid morphology (Fig 1C). Also, the readily visible presence of Mtb within the phago-
cytes reinforced the bacterial burden data at time-point 0 as assessed by bacterial burden (Fig
1B and 1C). Thus, our data suggested that the T120 differentiated macrophages were ideally
suited for use in a co-culture model involving Mtb infection. Such a model offers a simplistic
overview of the interaction between the two major cell types within the granuloma, in vitro.
Direct recognition of infected mononuclear cells by T-cells is essential for the control of Mtb
[50]. Such models can facilitate mechanistic studies needed to ascertain the role of LAG-3 in
modulating anti-Mtb immune responses [24].
We also assessed the interaction between co-cultured macrophages and T-cells (Fig 2). Co-
cultures were stained for macrophages using a combination of CD68 and CD163 (in green),
Mtb using a specific antibody (red) and for non-macrophage cells (T-cells) using nucleolar
marker ToPro3 (blue) (Fig 2A) [31–34, 38, 39, 47, 49, 51–53]. T-cells accumulated in the
outer peripheral region of these co-cultures (Fig 2A). We next stained for macrophages
(CD68+CD163+, green), ToPro3 (blue), Mtb (red) and CD4s using an anti-CD4 antibody
(white) (Fig 2B) and were able to demonstrate the interaction between macrophages that
engulfed Mtb and CD4+ T cells (Fig 2B). These results validate our co-culture model as a
The effect of LAG-3 on T-cells in TB
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Fig 1. Comparison of Mtb-infected T24 monocytes vs. T120 differentiated macrophages. (A) Log10-bacterial burden at 0, 4, 24,
48 72, and 96h post-infection. T24 monocytes are indicated by red squares and blue circles indicate T120 differentiated
macrophages infected with Mtb. Cellular morphology and bacterial uptake at time-point 0 in Mtb-infected phagocytes that were
allowed to differentiate for (B) 24h and (C) 120h before infection. Cells were stained for MAC387 (green), Mtb (red), and To-PRO-3
(blue). Upper panels show medium magnification (40x), and lower panels indicate high magnification (63x). Data are means ± SEM
from 4 or 6 independent experiments. In Prism v6.0, a Two-Way ANOVA with Sidak’s multiple comparisons test was performed
where ****, P<0.0001; *, P<0.05.
https://doi.org/10.1371/journal.pone.0180413.g001
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macaque version of the various in-vitro granuloma models that have recently been developed
[54, 55]. We further investigated whether some of the T cells derived from the whole blood
(via PBMCs) or lungs of macaques were Mtb-specific. One million PBMCs or lung cells each
were stimulated as described earlier with either SEB as a positive control, or Mtb cell wall frac-
tion (CW; BEI resources) or using a media-only negative control. We found that between
0.25–0.5% of all cells thus obtained (i.e. between 25,000–50,000 cells) in each sample were able
to induce the production of IFN-γ in response to Mtb CW over and above negative control.
While IFN-γ is not the correlate of antigen-specific cytokine production, these results strongly
suggest that Mtb-specific T-cells were present in our co-cultures.
Silencing LAG-3 in the co-culture system
LAG-3 expression was silenced in CD4+ T-cells alone using a specific siRNA at time-point 0
(S2 Fig) [24, 32]. Of the four siRNAs originally designed to silence LAG-3 expression, one
resulted in significant (~85%) down-regulation of the intended target 24h post-transfection,
(S2 Fig). A scrambled nonspecific siRNA served as a control [32].
Fig 2. Interaction between macaque macrophages and CD4+ T-cells during co-culture is shown using multilabel confocal
microscopy. Immunostaining of cells positive for Mtb (red), macrophages (green), nuclei (blue) and a merge images (far right) (A). A
representative image of macrophage (green):CD4+ T-cell (white) co-culture (lower left panel) and an infected macrophage with Mtb
and associated with T-cell (lower right panel) (B); scale bars- 100 μm (A), 20 μm and 40 μm (B).
https://doi.org/10.1371/journal.pone.0180413.g002
The effect of LAG-3 on T-cells in TB
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The effect of LAG-3 silencing on macrophage bacterial burden in co-
cultures
A dramatic decrease occurred in the macrophage bacterial burden upon co-culture with CD4+
T-cells, and this effect was observed for both blood (Fig 3A) and lung (Fig 3B) derived cells.
While the bacterial load in macrophages alone remained constant for the first few days and
then gradually increased, the load in T-cell co-cultures reduced progressively, with the lowest
bacterial burden being found at the 96h time-point. Therefore, we were able to recapitulate the
in-vivo interaction of infected macrophages and T-cells in the co-cultures. In several animal
models, Mtb has been shown to replicate logarithmically for the first few weeks after experi-
mental infection, and the onset of the adaptive response is able to significantly check this bacil-
lary replication.
Moreover, silencing of LAG-3 expression reduced bacterial load over and above the effect
of adding CD4+s to infected macrophages, with both the kinetics of bacterial killing and the
magnitude of reduction in Mtb levels being greater when LAG-3 expression was silenced in
CD4+s prior to co-culture. This effect was more pronounced in T-cells derived from the
blood rather than the lungs of infected macaques. Hence, using two-factor repeated-mea-
sures ANOVA across time, the lower Mtb load in co-cultured macrophages as well as macro-
phages co-cultured with LAG-3 silenced blood-derived T-cells, was marginally significant
(P = 0.0574892) relative to infected macrophages (P<0.01) at 96h (Fig 3A). While a compara-
ble trend was observed in co-cultures set up with lung-derived T cells, the results were not
statistically significant across time (Fig 3B). This result is not surprising given that LAG-3
expressions following Mtb infection are much higher in the lung and the effect of RNAi on
LAG-3 transcripts were less pronounced in lung T cells. The decrease in bacterial burden
over time was also greater for co-cultures with LAG-3 expression silenced. Thus, in these co-
cultures, the bacterial load decrease was first observed at 48h when bacterial levels in regular
co-cultures were comparable to the control macrophages. On the contrary, while the bacil-
lary burden in co-cultures from lung derived T-cells was lower at 96h relative to the control
group (P<0.05 both for regular and LAG-3 silenced co-cultures), there was no statistically
significant difference between the burdens in the two types of co-cultures (P>0.05) (Fig 3B).
We have earlier reported that the pro-inflammatory cytokine expression profile of active TB
granulomas is ameliorated over time in macaques [31, 38], an observation supported by met-
abolic-imaging of lungs in this model [56]. Furthermore, very low frequencies of T-cells
derived from the lungs of Mtb-infected macaques express protection-associated cytokines
[57]. Taken together with these prior reports, the co-culture results suggest that the lung
environment is anti-inflammatory during the chronic stages of Mtb infection, further under-
scoring the importance of LAG-3 and other checkpoint inhibitors, in this process.
LAG-3 silencing in CD4+ T-cells and its role on expression of
immunomodulatory proteins
Flow results were analyzed as shown (S3 Fig). In comparison to untreated blood-derived CD4+
T-cells, the frequency of LAG-3 positive CD4 T-cells in LAG-3 silenced blood-derived T cells
at times 72h and 96h post-infection, was essentially similar (Fig 4A). Whereas, a significant
decrease in the frequency of LAG-3+ occurred in silenced CD4+ T-cells from lung compared
to untreated lung-derived T-cells at 24h (5-fold) and 48h (3-fold) post-infection (Fig 4B).
During this time, we also observed the presence of both IL-10 and IFN-γ in CD4+ T-cells in
co-culture. The frequency of CD4+ T-cells expressing IFN-γ in both cultures increased over
the 96h course of infection and this frequency was only slightly lower in the LAG-3 silenced
CD4+ T-cells in comparison to the control co-cultures sans LAG-3 silencing (Fig 4C and 4D).
The effect of LAG-3 on T-cells in TB
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Fig 3. The effect of LAG-3 silencing on CD4+ T-cell killing of Mtb in a differentiated macrophage culture
supplemented with CD4+ T-cells. Log10-bacterial burden at 0, 24, 48 72, and 96h post-infection in
differentiated Mtb-infected macrophage cultures as well as co-cultures supplemented with CD4+ T-cells from
blood (A) or lung (B) of Mtb-infected animals. The CD4+ T-cells were either untreated, or were silenced for LAG-
3 with siRNA. The macrophage only cultures are indicated by solid circles, macrophage cultures supplemented
with CD4+ T-cells are represented by solid squares, and macrophage cultures supplemented with LAG-3
silenced CD4+ T-cells are represented by solid triangles. Statistical significance was determined using a two-
The effect of LAG-3 on T-cells in TB
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In T-cells derived from blood of Mtb-infected NHPs, a slight decrease in frequency occurred
at 48 and 72h post-infection (Fig 4C). In the co-culture model where CD4+ T-cells were iso-
lated from lungs of Mtb-infected animals, the frequency of IFN-γ positive T-cells appeared to
be lower at 24 and 48h post-infection in the LAG-3 silenced co-culture in comparison to the
untreated culture (Fig 3D). Thus, a decrease in LAG-3 levels in the CD4+ T-cells of macaques
due to RNA interference (RNAi) and the concomitant reduction in Mtb levels was not charac-
terized by a corresponding increase in IFN-γ levels. Interestingly, a similar frequency of IL-10
positive CD4+ T-cells in LAG-3 silenced CD4+ T-cells was observed when compared to
untreated cells (Fig 4E and 4F). In CD4+ T-cells isolated from blood, a decrease in the fre-
quency of IL-10 positive T-cells was observed at 48 and 72h post-infection (Fig 4E). Similarly,
a decrease in the frequency of IL-10 positive CD4+ T-cells occurred in lung-derived T-cells at
24 and 48h post-infection (Fig 4D).
The effect of LAG-3 silencing on cytokine production during co-culture
Sizeable differences in production of certain cytokines were observed in culture supernatants
within the various groups. 48h post-infection, we detected a significant increase in the concen-
tration of IFN-γ in the co-cultures with blood derived CD4+ T-cells where LAG-3 expression
was silenced relative to those where silencing was not performed (Fig 5A). Here, a measurable
increase in IFN-γ in the LAG-3 silenced co-culture and a decrease in the untreated co-culture
was observed whereas the mean IFN-γ concentration in the infected macrophages alone was at
an intermediate concentration. Silencing of LAG-3 also resulted in a significantly greater con-
centration of IL-6 (Fig 5B) and CXCL11 (Fig 5C) than controls. A contrasting pattern was
observed for the inflammatory mediator macrophage migration inhibitory factor (MIF) [58].
The highest concentration of MIF was found to be in the untreated co-cultures, while the
siRNA treated co-cultures had significantly decreased levels (Fig 5D).
Next, we went on to observe the differences between Mtb-infected macrophage cultures,
and untreated and LAG-3 siRNA treated co-cultures, where the CD4+ T-cells had been iso-
lated from lung of Mtb-infected NHPs. In these cultures, concentrations of IFN-γ were signifi-
cantly lower in both co-culture subsets when compared to the macrophage alone culture (Fig
6A). It is possible that this may be due to these specific CD4+ T-cells being from an immuno-
suppressive environment within the lungs [59]. In Mtb-infected NHPs, the frequency of CD4+
T-cells expressing LAG-3 was earlier shown by us to be significantly greater within the lung
when compared to blood from the same animals [32]. Similar results were observed with the
lung-derived CD4+ T-cells for both pro-inflammatory proteins IL-6 and CXCL11 as was previ-
ously observed with the blood-derived co-cultures, with levels being significantly lower in the
untreated co-culture group, and significantly greater in the LAG-3 silenced co-culture (Fig 6B
and 6C). The same was the case with MIF, where the silencing of LAG-3 resulted in a signifi-
cantly decreased concentration (Fig 6D). Thus, a similar pattern of cytokine production
occurred in co-cultures in response to inhibition of LAG-3 signaling, regardless of the source
of CD4+ T-cells. In general, the silencing of LAG-3 led to an increase in production of pro-
inflammatory cytokines (e.g. IFN-γ, IL-6 and CXCL11), and a decrease in those known to be
involved in immune inhibition (e.g. IL-10).
way ANOVA in Prism 6, with matched values stacked into sub columns, and using multiple comparisons to
compare effects within each row (time) by comparing each experimental condition (macrophage, co-culture or
LAG-3 RNAi co-culture) with every other condition at that time-point, with the Tukey multiple comparison test;
the mean and SEM are represented by horizontal bars. *p < 0.05, **p < 0.01.
https://doi.org/10.1371/journal.pone.0180413.g003
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Fig 4. LAG-3 silencing and its effect on CD4+ T cells within the Mtb-infected co-culture. This data
illustrates the mean frequency of CD4+ T cells positive for LAG-3 (A, B), IFN-γ (C, D), IL-10 (E, F), and Treg
frequency (G,H) over the course of 96h in the Mtb-infected macrophage co-culture. In all images, gray
squares indicate the Mtb-infected co-culture, where CD4+ T cell were untreated, and the black circles
represent the Mtb-infected co-culture, where CD4+ T cell were silenced for LAG-3 before being added to the
culture. In A, C, E, and G the CD4+ T cells used for co-culture were derived from blood of Mtb-infected rhesus
macaques, whereas in B, D, F, and H the CD4+ T cells were isolated from lung of Mtb-infected rhesus
The effect of LAG-3 on T-cells in TB
PLOS ONE | https://doi.org/10.1371/journal.pone.0180413 September 7, 2017 10 / 20
Transcriptomic analysis of the LAG-3 depleted co-culture model
We next used a sequential transcriptomic approach to analyze the impact of LAG-3 silencing
in blood- or lung-derived macaque CD4+ T-cells on the killing of Mtb within macaque macro-
phages. We first studied the impact of Mtb infection in macrophages at the 24h time-point,
then the impact of adding lung-derived CD4+s to these cultures, and finally the impact of add-
ing lung-derived CD4+ T-cells where LAG-3 expression had been silenced. ~250 genes exhib-
ited significant perturbation in levels of expression in macrophages infected with Mtb for 48h,
relative to uninfected cells, with ~150 exhibiting induction. The genes with strongest induction
included chemokines (e.g. CXCL11, 84-fold; CXCL10, 18-fold; CXCL9, 9-fold; CCL2, 9-fold)
and cytokines (e.g. IL6, 54-fold; IL12B, 10-fold; IL1B, 9-fold;) etc. (Table 1) consistent with the
infection of host phagocytes with Mtb reported earlier by us [33, 34].
macaques. Multiple t-tests corrected for multiple comparisons using the Holm-Sidak method were utilized to
determine significance between time points. Horizontal bars represent the SEM. *P < 0.05.
https://doi.org/10.1371/journal.pone.0180413.g004
Fig 5. The effect of LAG-3 silencing on cytokine production in co-cultures supplemented with CD4+ T-cells from the
blood of Mtb-infected rhesus macaques. (A) Production of IFN-γ in Mtb-infected macrophage culture, untreated co-
cultures, and LAG-3 silenced co-cultures at 0, 24, and 48h post-infection. (B) The presence of IL-6 and (C) CXCL11 in Mtb-
infected macrophage culture, untreated co-culture, and LAG-3 silenced co-culture at 48h post-infection. (D) Levels of MIF in
Mtb-infected macrophage culture, untreated co-culture, and LAG-3 silenced co-culture supernatant at 24h post-infection. All
samples were measured in pg/ml. Statistical significance was determined using a one-way ANOVA in Prism 6, using multiple
comparisons to compare each mean, with the Tukey multiple comparison test; the mean and SEM are represented by
horizontal bars. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
https://doi.org/10.1371/journal.pone.0180413.g005
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Significantly more genes exhibited perturbation in experiments where CD4+ T-cells
obtained from the lungs of infected rhesus macaques were added to infected macrophages,
with or without RNAi. This was unsurprising, both because CD4+ T-cells would be expected
to bring their own transcriptomic signature, but also because their interaction with Mtb-
infected macrophages could result in further changes to gene-expression. The expression of
~1300 genes was induced 24h after infected lung CD4+ T-cells were added to Mtb-infected
macrophages, with the expression of ~1700 genes being repressed. The expression of a very
similar number (~1400 genes with induced and ~1700 genes with repressed) was perturbed
when lung-derived CD4+ T-cells had been silenced by specific RNAi, were added to Mtb-
infected macrophages.
The genes with strongest induction in co-cultures included membrane-spanning 4-domains,
subfamily A, member 6A (MS4A6A), transcript variant 3 (120-fold), alcohol dehydrogenase 7
(ADH7) (41-fold), transforming growth factor, beta-induced (TGFBI) (36-fold), CXCL11
Fig 6. The effect of LAG-3 silencing on cytokine production in co-cultures supplemented with CD4+ T-cells isolated the
lung of Mtb-infected rhesus macaques. (A) Concentrations of IFN-γ, (B) IL-6 and (C) CXCL11 in Mtb-infected macrophage
culture, untreated co-culture, and LAG-3 silenced co-culture at 48h post-infection. (D) The presence of MIF in Mtb-infected
macrophage culture, untreated co-culture, and LAG-3 silenced co-culture at 24h post-infection. All samples were measured in pg/ml.
Statistical significance was determined using a one-way ANOVA in Prism 6, using multiple comparisons to compare each mean, with
the Tukey multiple comparison test; the mean and SEM are represented by horizontal bars. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001.
https://doi.org/10.1371/journal.pone.0180413.g006
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(29-fold), CXCL10 (14-fold), CXCL9 (13-fold) and CCL2 (7-fold). However, the expression of
most pro-inflammatory cytokines produced by infected macrophages (e.g. IL6, IL1B, IL12B
etc.), was abrogated in the macrophage-T cell co-cultures (Table 1). Thus, the significant pro-
inflammatory response triggered by the infection of macrophages by Mtb was curtailed upon
addition of lung CD4+ T-cells. However, the expression of numerous immune function genes,
particularly those belonging to the cytokine/chemokine families was induced to a higher level
in co-cultures where LAG-3 expression was silenced (Table 1), correlating with greater bacterial
killing and revealing a definite immunosuppressive function for LAG-3 in the context of TB.
The genes with the largest level of induction included MS4A6A, transcript variant 3 (140-fold)
and ADH7 (69-fold). Amongst chemokines, the expression of CXCL11 (45-fold), CXCL10
(18-fold), CXCL9 (15-fold) and CCL2 (5-fold) remained unperturbed relative to the second
group, while the expression of pro-inflammatory cytokines was not detected.
Due to the high similarly in transcriptomic results from two co-cultures, we used DAVID
as a tool to understand minute differences therein. The two groups with CD4+ T-cells added to
Mtb-infected macrophages appeared quite different from the Mtb-infected macrophage only
group with the addition of T cells ameliorating a highly proliferative and inflammatory
response in macrophages (Fig 7A). The expression of IL1B was maximally induced in infected
macrophages (~40-fold) by RT-PCR, relative to the co-cultures (Fig 7B), validating the higher
cytokine storm experienced by the pathogen in macrophages. Differences between the
Table 1. Log2 average fold change values of gene expression for select immune function genes
amongst biological replicate samples from Mtb-infected macrophages (24h) as well as the two co-cul-
ture sets (Mtb-infected macrophages (24h) + infected lung CD4+ T-cells; Mtb-infected macrophages
(24h) + infected lung CD4+ T-cells where LAG-3 expression was silenced by RNAi).
Gene (Symbol) Macs+Mtb Macs+Mtb+ILU CD4 Macs+Mtb+ILU CD4 (LAG3 siRNA)
CCL2 1.53 0.15 -2.37
CCL3 1.24 0.97 4.29
CCL5 0.74 0.15 -2.37
CCL15 0.98 0.84 -2.06
CCL18 1.59 -0.79 -0.86
CCR5 0.61 -0.18 0.86
CCR7 1.08 -0.30 4.24
CXCL2 1.69 1.42 4.57
CXCL6 0 0 5.87
CXCL9 1.07 0.87 -3.94
CXCL13 2.25 3.25 3.10
CXCL14 2.05 0 1.12
CXCR6 1.20 0.97 1.33
GADD45A 2.90 0.68 3.18
IL1R2 1.34 1.36 0.42
IL1RL1LG 0.65 0.10 0.65
IL12RB2 0.97 0.86 2.22
IL17RC 0.60 -0.08 0.18
IL21R 0.92 0.65 2.15
IL23A 1.95 0.53 2.15
IL27RA 0.95 0.71 -0.80
IL4R 0.63 0.15 0.89
NFIL3 1.48 0.26 1.68
PTGS2 1.66 1.40 5.36
https://doi.org/10.1371/journal.pone.0180413.t001
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Fig 7. Global transcriptomic impact of silencing LAG-3 expression in macrophage-T-cell co-cultures
during Mtb infection. Hierarchical clustering of specific gene ontology (GO) categories keywords or pathways
revealed that immune activation/inflammation genes were represented to significantly higher levels in macrophages
infected with Mtb and to lower levels in co-cultures (A). Mitochondrial electron transport related categories were
significantly overrepresented in co-cultures of macrophages and lung derived CD4+ T-cells (B and C), but the over
representation of these functions was ameliorated in co-cultures where LAG-3 expression was silenced by RNAi (B
and C). The red color represents higher significance while the blue color represents lower significance. The values
represented are negative log10 of significance p-values of accumulation using DAVID.
https://doi.org/10.1371/journal.pone.0180413.g007
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untreated and the LAG-3 specific siRNA groups, where CD4+ T-cells were co-cultured with
infected macrophages, were centered on cellular respiration and electron transport chain.
Thus, genes involved in these processes (e.g. GO terms cellular oxidative phosphorylation; cel-
lular respiration; electron transport chain; electron carrier activity; respiratory chain; oxidore-
ductase, acting on NADH/NADPH etc.) were induced to significantly higher levels in co-
cultures where LAG-3 expression was not silenced in CD4+ T-cells relative to where it was (Fig
7C). Furthermore, the enrichment of mitochondria-specific GO terms (e.g. organelle mem-
brane/inner membrane; mitochondrial membrane/inner membrane; mitochondrion and
mitochondrial envelope) in co-cultures of Mtb-infected macrophages with CD4+ T-cells was
reduced when LAG-3 expression was silenced in T-cells prior to co-culturing (Fig 7D). On the
other hand, genes belonging to GO terms lysosome and lytic vacuole were enriched in LAG-3
silenced co-cultures. The expression of SOD2 (superoxide dismutase 2, mitochondrial) was
found to be highest in co-cultures of infected macrophages and CD4+ T-cells, followed by co-
cultures where the T-cells has been incubated with LAG-3 specific siRNA, by RT-PCR, and
these differences were statistically significant (Fig 7E). Since the Mtb-load difference between
the two co-culture groups was not huge, especially when compared to the Mtb-infected macro-
phage cultures, it is unlikely that differences in mitochondrial gene-expression are a result of
changes in inflammation. Our results therefore, strongly suggest that LAG-3 specific modula-
tion of Th1 responses is mediated by interference with lysosomal function and enhanced mito-
chondrial electron transport. LAG-3 could therefore modulate adaptive immunity to Mtb
infection by interfering with the mitochondrial apoptosis pathway.
Discussion
Mtb owes is pathogenic success to its remarkably different strategy of interacting with its
human host, with which it has co-evolved [4]. Thus, while most pathogens attempt to mask
their immunogenicity, Mtb is rather unique in being able to elicit extremely high immune
responses, as exemplified by the use of BCG as an adjuvant4. This is counterintuitive and Mtb
appears to have evolved to retain and promote its immunogenicity. This is crucial in order to
generate the classical tissue damage associated with TB—which is itself necessary for the trans-
mission of Mtb. However, in order to complete this cycle, Mtb must first successfully persist in
the wake of strong immune responses it elicits. Several lines of evidence indicate that Mtb suc-
cessfully modulates host innate and adaptive immune responses [60]. Furthermore, IFN-γ is
critical for the control of Mtb, which interferes with IFN-γ signaling at several steps [61, 62].
Recent studies show active subversion of specific granuloma immune mechanisms by Mtb
within the granuloma. The expression of LAG-3 is highly induced in the granuloma during
active TB [32] and occurs largely on CD4+ T-cells [32]. LAG-3 is a marker for chronically
exhausted CD4 T cells [28] and its expression correlates with suppressed CD4+ T-cell
responses [63]. Additionally, the expression of LAG-3 has been shown to facilitate the immu-
nomodulatory function of Tregs [64] and NK/NKT cells [65] in a variety of scenarios includ-
ing autoimmunity and cancer.
Blockading LAG-3 allowed CD4 cells to kill significantly more Mtb, accompanied by
increased IFN-γ- and depressed IL-10-signaling. Together with our prior observation that
LAG-3 is chiefly expressed on lung CD4+ T-cells that also co-express IL-10 [32], these results
clearly show that IL-10-LAG-3 axis is crucial for the modulation of CD4+ T-cell responses to
Mtb within the granuloma. Consistent with our previously published work, current data sug-
gests that LAG-3 expression primarily occurs in tissues (in this case lung, and specifically the
granuloma) rather than in the periphery [32]. Similar observations were made during the
course of the current study. Silencing LAG-3 expression in blood- rather than lung-derived
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CD4s led to significant restriction of Mtb, likely due to an incomplete effect of RNAi on the
levels of a stable protein in the cell membrane fraction (Fig 3). We conclude that Mtb actively
reprograms the phenotype of antigen-specific T-cells at the site of infection for its own benefit.
In support of this, only a fraction of total T-cells in the Mtb-induced lung lesion express high
levels of protective cytokines [57].
To further elucidate the mechanism of LAG-3 we hope to take advantage of mice with
LAG-3 knockouts and the possibility of targeted removal of this allele in murine T-cells. It
may also be possible to perform in-vivo inhibition of LAG-3 signaling in macaques to better
understand its role, using fusion proteins or depleting antibodies. Inhibition of LAG-3 activity
could potentially be a host-based target towards, along the lines of immunotherapies against
cancer that are being developed using LAG-3.
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